The serum lithium concentration was 0 5 mmol/l. Platelet counts over the previous nine years had been normal. Lithium was withdrawn and the platelet count recovered to 125 x 101/l. When lithium was reinstated at 500 mg daily the platelet count fell to 100x 109/1. Chlorpromazine was introduced as the woman's mental state deteriorated. With advice that lithium could be continued while the platelet count remained over 95 x I0 /l, the dose was increased to regain a therapeutic concentration. After nine days, and at a lithium concentration of 0 6 mmoU/l, the platelet count had fallen further. Lithium was stopped, allowing recovery. The leucocyte count was now 8 x 10/l, the leucocytosis having been attributed to a productive cough which subsided without treatment. A 38 year old white woman presented in February 1991 with severe distal proctitis. She was treated with prednisolone suppositories 5 mg at night and sulphasalazine 1-5 g/day. Within a few days she developed a systemic illness with fever, malaise, and flu-like symptoms. The sulphasalazine was discontinued, with prompt resolution of her symptoms. After a week she was started on mesalazine 1-2 g/day with no ill effects. Seven months later she presented with a five week history of pleuritic central chest pain radiating to the left shoulder, increasing dyspnoea, night sweats, and extreme lassitude. On examination she looked unwell with a fever of 38 5°C, tachycardia, and signs of a left pleural effusion.
Electrocardiography showed a reduced QRS voltage and widespread T wave inversion. Chest radiography showed an enlarged cardiac silhouette and confirmed a left pleural effusion. Echocardiography showed good left ventricular function (ejection fraction 81%) and a moderate sized pericardial effusion without evidence of tamponade. Viral serology gave negative results while immunoserological investigations were strongly positive for antinuclear antibody (1/300) and negative for rheumatoid factor and double strand DNA, nuclear histone, smooth muscle, and mitochondrial antibodies. Both IgM and IgG immune complexes were present. C3 concentration was normal while C4 was marginally depressed at 0-19 g/l (normal 0 20-0-65). Drug induced lupus syndrome was diagnosed and mesalazine discontinued. Within 24 hours the patient's temperature had settled while the effusions and lassitude resolved over eight weeks. Immune profile returned to normal, though antinuclear factor was still present (1/100) two months later.
Pericarditis associated with sulphasalazine induced lupus syndrome is well recognised.' 2 The sulphapyridine moiety has been suggested as the most likely causative agent' and no similar reaction has yet been reported with mesalazine, which lacks the sulphapyridine group. Pericarditis has been reported after mesalazine, but the onset within two weeks of treatment and negative immunoserological findings were not typical of lupus-like syndrome.3 Our patient developed symptoms some months after starting treatment and presented with large effusions and immunoserological findings compatible with drug induced lupus syndrome. Immunoserological findings were not available from her previous reaction to sulphasalazine, which might have been a similar reaction, although its early onset was more characteristic of the commoner nonlupus type of hypersensitivity reaction. We suggest that the sulphapyridine moiety is not necessary for the development of lupus syndrome with this class of drugs and that such a reaction should be considered in patients who become unwell after several months of treatment.
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